Study of Acid Peel and Laser for the Treatment of Melasma
Not Applicable
Completed
- Conditions
- Melasma
- Registration Number
- NCT00467233
- Lead Sponsor
- Northwestern University
- Brief Summary
The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.
- Detailed Description
The purpose of this study is to evaluate the safety and efficacy of laser treatment and acid peel for the treatment of melasma.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Diagnosis of melasma lesion measuring at least 4 square centimeters.
- Age 18-75 years.
- Good health.
- Willingness and ability to understand and provide informed consent for participation in the study.
- Ability to communicate with the investigator.
- Must be willing to forgo other treatment options for melasma during the course of the study.
Exclusion Criteria
- Inability to understand the protocol or to give informed consent.
- Mental illness.
- Under 18 years of age and over 75 years of age.
- Laser treatment in the last 6 months before enrollment.
- Isotretinoin within the past year.
- Lidocaine allergy.
- History of herpes simplex viral infection.
- Concurrent active disease to facial area (i.e acne).
- Bleeding disorder.
- History of abnormal wound healing.
- History of abnormal scarring.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method MASI 20 weeks
- Secondary Outcome Measures
Name Time Method Safety 20 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does Q-switched Nd:YAG laser compare to 30% salicylic acid peel in modulating melanogenesis pathways for melasma?
What is the efficacy of NCT00467233 interventions versus standard-of-care hydroquinone in melasma treatment?
Which biomarkers predict response to 30% salicylic acid peels or Q-switched Nd:YAG lasers in melasma patients?
What are the adverse event profiles of Q-switched Nd:YAG laser and 30% salicylic acid peel for melasma?
Are there synergistic effects when combining 30% salicylic acid peels with Q-switched Nd:YAG laser therapy for melasma?
Trial Locations
- Locations (1)
Northwestern University Feinberg School of Medicine, Department of Dermatology
🇺🇸Chicago, Illinois, United States
Northwestern University Feinberg School of Medicine, Department of Dermatology🇺🇸Chicago, Illinois, United States